NO822546L - PARAMAGNETIC COMPLEX SALTS, MANUFACTURING THEREOF AND USE IN THE NMR DIAGNOSTICS - Google Patents

PARAMAGNETIC COMPLEX SALTS, MANUFACTURING THEREOF AND USE IN THE NMR DIAGNOSTICS

Info

Publication number
NO822546L
NO822546L NO822546A NO822546A NO822546L NO 822546 L NO822546 L NO 822546L NO 822546 A NO822546 A NO 822546A NO 822546 A NO822546 A NO 822546A NO 822546 L NO822546 L NO 822546L
Authority
NO
Norway
Prior art keywords
numbers
see diagramm
manufacturing
paramagnetic complex
nmr diagnostics
Prior art date
Application number
NO822546A
Other languages
Norwegian (no)
Other versions
NO164458C (en
NO164458B (en
Inventor
Heinz Gries
Douwe Rosenberg
Hans-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6137999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO822546(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO822546L publication Critical patent/NO822546L/en
Publication of NO164458B publication Critical patent/NO164458B/en
Publication of NO164458C publication Critical patent/NO164458C/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281—Means for the use of in vitro contrast agents

Abstract

1. The use of at least one physiologically tolerable paramagnetic complex salt made from aminopolycarboxylic acids having the formulae I to IV see diagramm : EP0169299,P6,F1 N-hydroxyethyl-N,N',N'-ethylenediaminetriacetic acid (HEDTA), see diagramm : EP0169299,P6,F2 N,N,N',N",N"-diethylenetriaminepenta-acetic acid (DTPA), HOH2 C-CH2 N(CH2 COOH)2 N-hydroxyethylimino-diacetic acid, see diagramm : EP0169299,P6,F3 wherein m represents the numbers 1 to 4, n the numbers 0 to 2, R**1 a saturated or unsaturated hydrocarbon radical having from 4 to 12 hydrocarbon atoms or the group -CH2 -COOH, and from the ions of the lanthanide elements having the atomic numbers 57 to 70 or from the ions of the transition metals having the atomic numbers 21 to 29, 42 and 44 and, optionally from an inorganic base for the preparation of agents for NMR diagnostics.
NO822546A 1981-07-24 1982-07-23 PHYSIOLOGICALLY COMPATIBLE, PARAMAGNETIC COMPLEX SALTS AND AGENTS FOR USE IN NMR DIAGNOSTICS NO164458C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3129906A DE3129906C3 (en) 1981-07-24 1981-07-24 Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics

Publications (3)

Publication Number Publication Date
NO822546L true NO822546L (en) 1983-01-25
NO164458B NO164458B (en) 1990-07-02
NO164458C NO164458C (en) 1992-11-23

Family

ID=6137999

Family Applications (2)

Application Number Title Priority Date Filing Date
NO822546A NO164458C (en) 1981-07-24 1982-07-23 PHYSIOLOGICALLY COMPATIBLE, PARAMAGNETIC COMPLEX SALTS AND AGENTS FOR USE IN NMR DIAGNOSTICS
NO1994031C NO1994031I1 (en) 1981-07-24 1994-12-30 The dimeglumine salt of gadopentetic acid / (di-N-methylglucamine salt of gadolinium (III) complex of diethylenetriaminepentaacetic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1994031C NO1994031I1 (en) 1981-07-24 1994-12-30 The dimeglumine salt of gadopentetic acid / (di-N-methylglucamine salt of gadolinium (III) complex of diethylenetriaminepentaacetic acid

Country Status (12)

Country Link
EP (2) EP0169299B1 (en)
JP (3) JPS5829718A (en)
AT (2) ATE52247T1 (en)
AU (2) AU566007B2 (en)
CA (2) CA1218597A (en)
DE (3) DE3129906C3 (en)
IE (1) IE53639B1 (en)
LU (1) LU88291I2 (en)
NL (1) NL930072I2 (en)
NO (2) NO164458C (en)
NZ (1) NZ201372A (en)
ZA (1) ZA825313B (en)

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
DE3448606C2 (en) * 1983-01-21 2001-12-13 Schering Ag Diagnostic agents, processes for their production and their use
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
EP0330801A1 (en) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
SE8301395L (en) * 1983-03-15 1984-09-16 Wallac Oy KELATIZING COMPOUNDS WITH FUNCTIONAL GROUPS WHICH ALLOW COVALENT COUPLING TO BIO-ORGANIC MOLECULES
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
DE3316703A1 (en) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen ORAL CONTRAST AGENT FOR MRI MRI AND THE PRODUCTION THEREOF
DE3324235A1 (en) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen NEW COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS
DE3328365A1 (en) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen NEW DIAGNOSTIC AGENTS
FR2550449B1 (en) * 1983-08-12 1986-01-31 Commissariat Energie Atomique SPECIFIC ORGAN OR PATHOLOGY RELAXATION AGENTS FOR USE IN MODIFYING CONTRASTS IN MEDICAL IMAGING BY NUCLEAR MAGNETIC RESONANCE
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
CA1243602A (en) * 1983-08-25 1988-10-25 Hong-Ning Yeung Methods for enhancing the contrast in nmr imaging
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US5618514A (en) 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
GB8413849D0 (en) * 1984-05-31 1984-07-04 Amersham Int Plc Nmr contrast agents
CA1268208A (en) * 1984-08-10 1990-04-24 Truman Brown Magnetic micro-particles as contrast agents in nuclear magnetic resonance imaging
US4859450A (en) * 1984-08-13 1989-08-22 The General Hospital Corporation Method of NMR imaging using antibody to cardiac myosin
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4687659A (en) 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US5362476A (en) * 1984-10-18 1994-11-08 Board Of Regents, The University Of Texas System Alkyl phosphonate polyazamacrocyclic cheates for MRI
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
US5342606A (en) * 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
SE465907B (en) * 1984-11-01 1991-11-18 Nyegaard & Co As DIAGNOSTIC AGENT CONTENT AND PARAMAGNETIC METAL
PT81498B (en) * 1984-11-23 1987-12-30 Schering Ag METHOD FOR PREPARING COMPOSITIONS FOR DIAGNOSTICS CONTAINING MAGNETIC PARTICLES
DE3443252A1 (en) * 1984-11-23 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Dextran-magnetite complexes for NMR diagnosis
DE3508000A1 (en) * 1985-03-04 1986-09-04 Schering AG, Berlin und Bergkamen, 1000 Berlin Ferromagnetic particles for NMR diagnosis
DE3443251C2 (en) * 1984-11-23 1998-03-12 Schering Ag Iron oxide complexes for NMR diagnosis, diagnostic compounds containing these compounds, their use and process for their preparation
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4746507A (en) * 1985-04-02 1988-05-24 Salutar, Inc. EDHPA based contrast agents for MR imaging, apparatus and methods
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
JPH07110815B2 (en) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム Polychelating agent for image and spectral enhancement (and spectral shift)
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (en) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-TRISCARBOXIMETHYL-1,4,7,10-TETRAAZACICLODO DECAN SUBSTITUTE IN 1 AND ANALOG COMPOUNDS
EP0232751B1 (en) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
IT1213029B (en) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa PARAMAGNETIC METAL ION CHELATES.
JPS62231168A (en) * 1986-03-21 1987-10-09 ハイブリテツク・インコ−ポレイテツド Improvement method for forming internal standard for analyzing analite-receptor
HU200104B (en) * 1986-04-07 1990-04-28 Francois Dietlin New contrast composition for tomodensitometry
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
DE3640708C2 (en) * 1986-11-28 1995-05-18 Schering Ag Improved pharmaceuticals containing metals
GB8700431D0 (en) * 1987-01-09 1987-02-11 Amersham Int Plc Contrast agents
DE3709851A1 (en) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te NMR DIAGNOSTIC LIQUID COMPOSITIONS
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
IE61448B1 (en) * 1987-06-23 1994-11-02 Hafslund Nycomed Innovation Improvements in and relating to magnetic resonance imaging
US5531978A (en) * 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
JP2833766B2 (en) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト Aminopolycarboxylic acid and its derivatives
DE3724188C2 (en) * 1987-07-17 1995-05-18 Heinz Dr Gries Metal-containing oligosaccharide polysulfates, process for their preparation and pharmaceutical compositions containing them
DE3927444A1 (en) * 1989-08-16 1991-02-28 Schering Ag USE OF AMID COMPLEX COMPOUNDS
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
DE3806795A1 (en) * 1988-02-29 1989-09-07 Schering Ag POLYMER-TIED COMPLEX IMAGERS, THEIR COMPLEXES AND CONJUGATES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE3809671A1 (en) * 1988-03-18 1989-09-28 Schering Ag PORPHYRINE COMPLEX COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE68927479T2 (en) * 1988-05-02 1997-04-03 Phanos Tech Inc CONNECTIONS, COMPOSITIONS AND METHOD FOR BINDING ORGANIC AFFECTION SUBSTANCES TO SURFACE MEMBRANES OF BIOPARTICLES
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
GB8817137D0 (en) * 1988-07-19 1988-08-24 Nycomed As Compositions
US5137711A (en) † 1988-07-19 1992-08-11 Mallickrodt Medical, Inc. Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
DE3825040A1 (en) * 1988-07-20 1990-01-25 Schering Ag 5- OR 6-RING MACROCYCLIC POLYAZA COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE4001655A1 (en) * 1990-01-18 1991-07-25 Schering Ag 6-RING MACROCYCLIC TETRAAZA COMPOUNDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM
DE68926708T2 (en) * 1988-08-04 1996-10-31 Advanced Magnetics Inc CONTRAST AGENT FOR ENDOCYTOSE TYPE MRI INDUCED BY A RECEPTOR
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
FR2654344B1 (en) * 1989-11-16 1994-09-23 Cis Bio Int GADOLINIUM PARAMAGNETIC COMPLEX, ITS PREPARATION METHOD AND ITS USE FOR MRI DIAGNOSIS.
US5516503A (en) * 1989-11-16 1996-05-14 Guerbet S.A. Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
DE3938992A1 (en) * 1989-11-21 1991-05-23 Schering Ag Cascade polymer-bound complex formers, their complexes and conjugates, process for their preparation and pharmaceutical compositions containing them
EP0513000B1 (en) * 1989-11-27 1996-07-31 Concat Ltd. Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
CH679742A5 (en) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab
JP3131219B2 (en) * 1990-01-19 2001-01-31 ニユコメド・イメージング・アクシエセルカペト Chelate compounds
FR2667506B1 (en) * 1990-10-05 1993-08-20 Medgenix Group Sa CONTRAST AGENT COMPRISING A PARAMAGNETIC CATION ASSOCIATED WITH A SCHIFF BASE.
FR2670113A1 (en) * 1990-12-06 1992-06-12 Medgenix Group Sa CONTRAST AGENT CONSTITUTED BY A NEUTRAL COMPLEX OF A PARAMAGNETIC CATION AND LIGAND TO FORM A COMPLEX.
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5360459A (en) 1991-05-13 1994-11-01 The Lubrizol Corporation Copper-containing organometallic complexes and concentrates and diesel fuels containing same
GB9208908D0 (en) * 1992-04-24 1992-06-10 Nycomed As Contrast agents
DE4302287A1 (en) * 1993-01-25 1994-07-28 Schering Ag Derivatized DTPA complexes, pharmaceutical compositions containing these compounds, their use and processes for their preparation
DE4340809C2 (en) * 1993-11-24 2000-08-03 Schering Ag 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
TW319763B (en) 1995-02-01 1997-11-11 Epix Medical Inc
DE19507819A1 (en) * 1995-02-21 1996-08-22 Schering Ag New di:ethylene-tri:amine penta:acetic acid amide complexes
DE19507822B4 (en) * 1995-02-21 2006-07-20 Schering Ag Substituted DTPA monoamides of the central carboxylic acid and its metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics and therapy, and methods for the preparation of the complexes and agents
DE19508058A1 (en) * 1995-02-21 1996-08-22 Schering Ag Process for the preparation of DTPA tetraesters of the terminal carboxylic acids and their use for the production of pharmaceutical agents
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
DE19646762B4 (en) * 1996-11-04 2004-05-13 Schering Ag Use of metal compounds for the production of agents for radiotherapy of tumors
DE19719033C1 (en) * 1997-04-29 1999-01-28 Schering Ag Ion pairs, processes for their preparation and their use as contrast agents
DE69826528T2 (en) * 1997-12-23 2006-02-23 Amersham Health As NITROGEN OXIDE RELEASING CHELATE FIGURES AND THEIR USE THERAPEUTIC
IT1297035B1 (en) 1997-12-30 1999-08-03 Bracco Spa 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES
US7169410B1 (en) 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
DE19964224B4 (en) * 1999-09-09 2005-09-01 Schering Ag Pharmaceutical compositions containing calcium complex of [[(4R) -4- [bis [(carboxy-.kappa.O) methyl] amino-.kappa.N] -6,9-bis [(carboxy-.kappa.O) methyl] -1 - [(4,4-diphenylcyclohexyl) oxy] -1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.011] 1-oxidato (6 -)], tetrahydrogen (MS-325) and its salts, and process for their preparation
US6559330B1 (en) 1999-09-09 2003-05-06 Schering Aktiengesellschaft Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
PT1072604E (en) * 1999-09-09 2001-08-30 Schering Ag (4R) -4-BIS (CARBOXY-KAPPA.O) METHYL AMINO-.KAPPA.N-6,9-BIS (CARBOXY-.KAPPA.O) METHYL-1- (4,4-DIPHENYLCYLO- HEXYL) OXY-1-HYDROXY-2-OXA-6,9-DIAZA-1-PHOSPHOUNDECAN-11.OIC.KAPPA.N6, .KAPPA.N9, .KAPPA.O11 1-OXIDATE (6 -) -, HEXA -HYDROGENATED ITS SALTS PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEX THEIR THERAPEUTIC UTILIZATION AND AS ADDITIVES IN DIAGNOSTIC AGENTS AND A PROCESS FOR THE PREPARATION OF COMPLEXES AND AGENTS
DE19944893C2 (en) * 1999-09-09 2001-09-20 Schering Ag Calcium complex of [[(4R) -4- [bis [(carboxy-.kappa.O) methyl] amino-. kappa.N] -6,9-bis [(carboxy-.kappa.O) methyl] -1 - [(4,4-diphenylcyclohexyl) oxy] -1-hydroxy-2-oxa-6,9-diaza-1 -phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.O11] 1-oxidato (6 -)] -, hexahydrogen, its salts and pharmaceutical compositions containing these complexes
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
DE10305462A1 (en) * 2003-02-04 2004-08-12 Schering Ag Conjugates of enantiomerically pure (4S, 8S) - and (4R, 8R) -4-p-benzyl-8-methyl-3,6,9-triaza-3N, 6N, 9N-tricarboxymethyl-1,11-undecanedioic acid with biomolecules, method for their manufacture and use for manufacture
FR2867473B1 (en) 2004-03-12 2006-06-23 Guerbet Sa PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI
WO2006002873A2 (en) 2004-07-02 2006-01-12 Bracco Imaging Spa 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
US8669236B2 (en) 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
AR059193A1 (en) 2006-01-31 2008-03-12 Bayer Schering Pharma Ag MODULATION OF THE ACTIVITY OF MDL-1 FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE102007058220A1 (en) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors
WO2009082485A1 (en) 2007-12-26 2009-07-02 Vaccinex, Inc. Anti-c35 antibody combination therapies and methods
US8722020B2 (en) * 2010-03-31 2014-05-13 General Electric Company Hydroxylated contrast enhancement agents
WO2014036427A1 (en) 2012-08-31 2014-03-06 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
CN103664672B (en) * 2013-10-21 2016-01-13 河北一品制药有限公司 A kind of preparation method of suitability for industrialized production Gadopentetate Meglumine
CN110114093A (en) 2016-12-29 2019-08-09 创意有限责任公司 Solvent-free gadolinium contrast agent
CN106928078A (en) * 2017-02-27 2017-07-07 南昌大学 A kind of threonine chelated iron and its application
CN107632037A (en) * 2017-08-24 2018-01-26 北京中科乾和环保科技服务有限公司 Based on liquid phase31The analysis method of organophosphor in the deposit of P NMR technologies

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US401594A (en) * 1889-04-16 Combined punch
FR1111504A (en) * 1950-03-06 1956-03-01 Cassella Farbwerke Mainkur Ag Process for the preparation of cobalt compounds
FR484M (en) * 1960-05-02 1961-05-08
FR988M (en) * 1960-12-01 1961-12-11
US3252082A (en) * 1964-01-02 1966-05-17 Chevron Res Method and composition for aiding nuclear magnetic well logging
US3818061A (en) * 1971-11-09 1974-06-18 Merck Sharp & Dohme Transparent nmr shift reagents
JPS5441575B2 (en) * 1972-07-28 1979-12-08
JPS49103693A (en) * 1973-02-02 1974-10-01
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
DE2527158A1 (en) * 1975-06-18 1976-12-23 Herz Eberhard MEDICINAL PRODUCTS FOR THE TREATMENT OF INFECTIOUS DISEASES AND INFLAMMATION IN HUMAN AND VETERINAL MEDICINE THAT CANNOT BE DETECTED BY MICROORGANISMS
US4066743A (en) * 1976-06-21 1978-01-03 Mallinckrodt, Inc. X-ray contrast agents
US4125599A (en) * 1976-08-19 1978-11-14 Mallinckrodt, Inc. X-ray contrast agents
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
NZ188912A (en) * 1977-12-01 1984-05-31 Ici Australia Ltd Prevention or treatment of copper deficiency by topical application of copper
GB1598610A (en) * 1978-05-31 1981-09-23 Rexolin Chem Ab Aliphatic polyamino polycarboxylic acid and its salts and their use as chelating agents
JPS5759841A (en) * 1980-09-30 1982-04-10 Showa Denko Kk Treating method of waste liquor from preparation of metallic chelate of ethylenediaminetraacetic acid
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3518267A1 (en) * 1985-05-17 1986-11-20 Martin Prof. Dr. 1000 Berlin Wenzel Compositions for increasing contrast in magnetic resonance imaging
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
IT1213029B (en) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa PARAMAGNETIC METAL ION CHELATES.

Also Published As

Publication number Publication date
AU601916B2 (en) 1990-09-20
DE3129906C2 (en) 1990-05-17
ATE52247T1 (en) 1990-05-15
JP2548436B2 (en) 1996-10-30
ATE18719T1 (en) 1986-04-15
JPS5829718A (en) 1983-02-22
DE3280157D1 (en) 1990-05-31
NO1994031I1 (en) 1994-12-30
CA1218597A (en) 1987-03-03
JPH0339045B2 (en) 1991-06-12
NO164458C (en) 1992-11-23
EP0169299A3 (en) 1986-12-03
EP0169299A2 (en) 1986-01-29
AU566007B2 (en) 1987-10-08
EP0071564A1 (en) 1983-02-09
NL930072I2 (en) 1994-01-17
JPS62123159A (en) 1987-06-04
JPH03209389A (en) 1991-09-12
EP0071564B1 (en) 1986-03-26
NZ201372A (en) 1986-08-08
ZA825313B (en) 1983-05-25
NL930072I1 (en) 1993-09-01
JPH0768193B2 (en) 1995-07-26
IE53639B1 (en) 1989-01-04
AU1018688A (en) 1988-04-28
IE821766L (en) 1983-01-24
NO164458B (en) 1990-07-02
CA1240679A (en) 1988-08-16
DE3270097D1 (en) 1986-04-30
AU8633082A (en) 1983-01-27
DE3129906A1 (en) 1983-02-10
EP0169299B1 (en) 1990-04-25
DE3129906C3 (en) 1996-12-19
LU88291I2 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
NO822546L (en) PARAMAGNETIC COMPLEX SALTS, MANUFACTURING THEREOF AND USE IN THE NMR DIAGNOSTICS
DE3777727D1 (en) KMR IMAGING WITH PARAMAGNETIC POLYVALENT METAL SALTS OF POLY- (ACID-ALKYLENE-AMINO) -ALKANES.
FI98988C (en) The contrast agents
EP0305320A3 (en) Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them
DK165170C (en) NMR CONTRAST AGENT CONTAINING AT LEAST A WATER SOLUBLE, PARAMAGNETIC NON-RADIOACTIVE METAL CHELATE, AND SUCH A CHELATE AND ITS USE
NO2005013I2 (en) Derivatized DTPA complexes and their use in NMR and X-ray diagnostics
ES2121816T3 (en) PROCEDURE AND DEVICE FOR THE PREPARATION OF A CONTRAST MEANS FROM A CONCENTRATE.
DE69320481T2 (en) TETRAAZAMACROCYCLIC METAL COMPLEXES
ES8604694A1 (en) Iodothyronine immunoassays employing HMS as TBP blocking agent.
DE3361263D1 (en) 2-acrylamido-2-methyl-propanephosphonic acids and their salts, process for their preparation
ES2090410T3 (en) PROCEDURE FOR MANUFACTURING MICROEMULSIONED HOMOPOLYMER OF ACRYLAMIDE.
DE3161506D1 (en) Process for preparation of aminoalcohols polyoxa-alkylated or polyoxa-arylated and their use as cation complexing agents
JPS5283594A (en) Bis-dithiolium salts
ES2027798T3 (en) PROCEDURE FOR THE OBTAINING OF PHENOLIC ESTERS OF THIOCARBOXYLIC ACIDS.
NO932251L (en) CHELATING RELATIONS
EP0224925A3 (en) Phosphorous compounds and medicines containing them
RO68131A2 (en) METHOD AND INSTALLATION FOR CONTROLLING AUTOMATIC TOTAL ATTACHMENTS USED AT THE ATTACHMENT

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JULY 2002